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Efficacy of a lutein-based dye (PhacodyneTM) for visualizing anterior capsulorhexis 
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INTRODUCTION
The continuous circular capsulotomy (CCC) of the anterior lens 
capsule is a critical step in the modern cataract surgery performed by 
phacoemulsification, which offers advantage for the implantation of 
intraocular lens correctly into the capsular bag(1). Good visualization 
of the anterior capsule flap is needed when performing the CCC, 
particularly in the absence of a red reflex(2-4). Since the lack of a red 
reflex results in technical difficulties(2-4), a correct CCC is useful when 
a more aggressive manipulation of the capsular bag is required(3). In 
such clinical conditions, the improvement of the anterior capsule 
ABSTRACT
Purpose: To evaluate the efficacy and safety of a novel lutein-based dye for the 
anterior capsulorhexis during phacoemulsification in cataract surgery in humans. 
Methods: Twenty-five eyes from 25 patients were operated by 25 different 
sur geons who performed continuous circular capsulorhexis (CCC) guided by a 
lutein-based dye (Phacodyne™) during cataract surgery by phacoemulsification. 
A questionnaire assessed the surgeon’s opinion regarding the efficacy of the dye. 
Follow-up examinations were performed at 1, 7, and 30 days post-surgery. Eyes 
were evaluated by full ophthalmic examination, corneal topography/pachymetry, 
and corneal endothelial cell count. 
Results: As revealed by the answers to the questionnaire, the dye facilitated the 
CCC procedure in all eyes. Baseline nuclear cataract classification (according to 
the Lens Opacities Classification System III; LOCS III) was 3.24 (± 1.12). Preoperative 
BCVA (logMAR) was 0.89 ± 0.59 and improved to 0.23 ± 0.22 on day 30 after surgery. 
The intraocular pressure (IOP) remained stable and the inflammatory reaction 
subsided in all cases within the first 7 days after surgery. The pre-operative values 
of corneal pachymetry and IOP were similar to those found on follow-up day 30. 
Loss in endothelial cell number was similar to earlier reports. 
Conclusion: Phacodyne™ was efficient when used for anterior capsulorhexis du ring 
cataract surgery by phacoemulsification and showed no signs of toxicity or side 
effects during the 30-day follow-up period. 
Keywords: Cataract extraction; Lutein; Phacoemulsification; Capsulorhexis; Lenses, 
intraocular
RESUMO
Objetivos: Avaliar a eficácia e eficiência de um novo corante à base de luteína para 
coloração da cápsula anterior durante cirurgia de facoemulsificação em humanos. 
Métodos: Vinte e cinco olhos de 25 pacientes foram operados por 25 cirurgiões 
di ferentes que realizaram capsulorrexis circular contínua e facoemulsificação após 
coloração da cápsula anterior com corante à base de luteína. Um questionário ava liou 
a opinião dos cirurgiões sobre a eficácia do corante. Exames pós-operatórios foram 
realizados nos dias 1, 7 e 30 por meio de exame oftalmológico completo, topografia/
paquimetria e contagem de células endoteliais. 
Resultados: De acordo com o questionário aplicado, o corante facilitou a cirurgia em 
todos os olhos. A classificação da catarata de acordo com o LOCS III foi de 3,24 ± 1,12. 
A acuidade visual pré-operatória com melhor correção foi de 0,89 ± 0,59 (logMAR), 
passando a 0,23 ± 0,22 no pós-operatório. A pressão intraocular (PIO) permaneceu 
estável e houve reação de câmara leve que desapareceu em todos os casos durante os 
primeiros 7 dias de pós-operatório. Não houve significância estatística comparando 
a paquimetria e PIO pré e pós-operatórios.
Conclusão: O novo corante se mostrou eficiente e sem sinais de toxicidade ou efeitos 
adversos, após 30 dias, quando usado para auxiliar a cirurgia de facoemulsificação. 
Descritores: Extração de catarata/métodos; Luteína; Facoemulsificação; Capsulorrexe; 
Lentes intraoculares
visualization can also be of great value for surgeons, particularly for 
those who are learning the surgical technique(4). Additionally, the 
surgical procedure of staining the anterior capsule during CCC in 
pediatric cataract extraction is useful since the anterior capsule of 
these eyes is thin and elastic(5).
Since the first use of fluorescein for improving the visualization 
during capsulorhexis in 1993(6), alternative techniques and a variety 
of dyes have been used for anterior capsule staining during cataract 
surgery(4). Although indocyanine green, trypan blue, sodium fluores-
cein, crystal violet, and gentian violet have been shown to be useful 
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for facilitating the CCC maneuver, only the trypan blue 0.06% - Vision 
blue™ (Dorc, Netherlands) has been approved by the FDA for use in 
cataract surgery(7,8).
New dyes that enhance the visualization of ocular tissues during 
surgery have recently emerged(9-11). Lutein and zeaxanthin are two 
major components of the macular pigment and are the only carote-
noids found in the macula and lens of humans. The antioxidant pro-
perties of the dyes and the ability to filter blue light facilitated their 
use during the CCC procedure(12,13).
It has been reported that the green 1% solution of soluble lutein 
and zeaxanthin-based dye combined with 0.04% trypan blue (Phaco-
dyne™, Kemin, USA) is a useful intraocular dye for staining the an terior 
capsule, enhancing the CCC procedure in human cadaveric eyes(11). Its 
safety profile has been evaluated by clinical, histological, and electro-
retinographic methods after intravitreal injections into rabbit eyes(14). 
The objective of this study was to evaluate the feasibility and safety 
of application of a novel dye comprising 1% soluble lutein-zeaxanthin 
together with 0.04% trypan blue (Phacodyne™, Kemin, USA) to improve 
the anterior capsulorhexis during the phacoemulsification surgery in 
human eyes.
METHODS
PreParation of the dye
The method of preparation described below is valid for lutein/
zeaxanthin regardless of the chemical form, purity, crystallization, or 
degree of esterification (patent office application #61/468,838).
The initial steps of this study were the development of a wa-
ter-soluble solution, characterization of the absorbance of the lutein/
zeaxanthin solution using the Aquamate device (Thermo Spectronic, 
Cambridge, UK), and the identification of the color of the chromo-
phoric groups. The physicochemical parameters were tested for the 
optimum pH, osmolarity/osmolality, and concentration. Solubility in 
water and polyvinyl alcohol was tested, the ultraviolet spectra were 
recoded, and the blends showing different colors within the visible 
spectrum were analyzed.
The method of preparation of the dye included dissolution, agita-
tion, sterilization, and filtration. First, the components were dissolved 
in balanced saline solution (BSS) or any other solution compatible 
with the components of the formula that provided stability, suitable 
pH, and osmolarity acceptable for ocular use. Sterilization using wet 
heat was achieved by autoclaving at 121ºC. The final dye solution 
contained 1% soluble lutein/zeaxanthin and 0.04% trypan blue (os-
molarity, 280 mOsm; density, 1.05; pH, 7.00). Aliquots of 1 mL were 
prepared, stored at room temperature, and were used within 30 days.
Study deSign
This was a prospective, consecutive, non-randomized, interven-
tional study of 25 eyes of 25 patients performed by 25 different 
sur geons. The study was registered at clinicaltrials.gov under the no 
NCT01627977. The study was approved by the Ethics Committee of 
the Federal University of São Paulo and was conducted according to 
the Research Guidelines of the Association of Research in Vision and 
Ophthalmology, adhering to the Declaration of Helsinki. All patients 
were informed of the benefits and risks of the surgical procedure as 
well as the nature and possible consequences of the new dye tested. 
This study was conducted after receiving informed consent from all 
participants.
Eyes were submitted to phacoemulsification at the Ophthalmo-
logy Department of Hospital São Paulo, Universidade Federal de São 
Paulo, Brazil, with PhacodyneTM (Kemin, USA) assisting the CCC technique 
and the hydrophilic foldable IOL implantation.
incluSion and excluSion criteria
Patients over 50 years of age with indication for cataract surgery 
in one eye were included in the study. Patients with any previous 
ocular surgeries in the eye studied, pregnancy, glaucoma, a past or 
present intraocular infection, and any other ocular condition detected 
during the pre-operative examination that could limit or affect the 
postoperative results were excluded. The minimum follow-up period 
was 30 days.
PhySical evaluation and ocular examinationS
All patients underwent a full ophthalmologic examination at the 
start of the study and postoperatively (days 1, 7, and 30). This inclu-
ded evaluation of the best-corrected visual acuity (BCVA) that was 
measured using the Snellen Charts and converted to logMAR, 
mea surement of the intraocular pressure (IOP) using the Goldmann 
tonometer, and slit-lamp evaluation. Complementary exams such 
as fundoscopy, pachymetry, and specular microscopy (CSO, Firenze, 
Italy) were also performed at the same time points. Baseline cataracts 
were graded according to the “Lens Opacities Classification System III” 
(LOCS III)(15). Anterior chamber reaction was graded according to SUN 
Working Group(16).
Surgical ProcedureS
The phacoemulsification was performed by 25 different experien-
ced cataract surgeons. The first step consisted of making a 2.75-mm 
clear corneal incision, filling the anterior chamber with Phacodyne™ 
(Kemin, USA), washing after 30 seconds with balanced salt solution, 
and filling the anterior chamber with viscoelastic. The anterior con-
tinuous circular capsulorhexis (CCC) (Figure 1) was performed using 
an Utrata forceps. This was followed by hydrodissection and hydrode-
lineation using approximately 0.1 mL BSS. Phacoemulsification was 
performed using the Infinity Vision System™ (Alcon, USA). Following 
this, the lens cortex was aspirated and a foldable intraocular lens was 
inserted through the 2.75-mm corneal incision (Figure 2). At the end 
of the surgical procedure, the viscoelastic substance was aspirated 
and no sutures were placed at the corneal incision. Moxifloxacyn and 
dexamethasone association - Vigadexa™ (Alcon, USA) eye drops were 
used during the immediate post-operative period.
Figure 1. Dark green color of the dye.
Figure 2. Anterior capsule staining with the solution containing 0.3% lutein/
zeaxanthin and 0.04% trypan blue, facilitating the CCC procedure.
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follow-uP
All eyes received 0.5% moxifloxacin eye drops 4 times daily for 7 
days and 0.1% dexamethasone as part of a regressive regimen. No hy-
potensive eye drops were prescribed. The eyes underwent an ophthal-
mologic examination at days 1, 7, and 30 by expert ophthalmologists. 
QueStionnaireS
Surgeons’ evaluation of the use of PhacodyneTM (Kemin, USA) for 
the CCC procedure was reported using a questionnaire.
StatiStical methodS
All data were presented as the mean and standard deviation for 
quantitative variables, and absolute (n) and relative (%) values for qua-
litative variables. The prevalence of intense staining of the anterior 
lens capsule was defined. The confidence interval was set at 95%.
RESULTS
intraoPerative findingS
The lutein-based dye produced a green solution (Figure 1) that 
stained the anterior capsule and facilitated the CCC procedure (Fi-
gure 2). The phacoemulsification followed by IOL implantation was 
performed as traditionally reported by cataract surgeons. No sutures 
were necessary. 
PhySical evaluation and ocular examinationS at baSeline and 
follow-uP
Nuclear cataract classification (according to LOCS III) was 3.24 ± 1.12 
and changed from 2 to 6 in both groups. Preoperative BCVA (logMAR) 
was 0.89 ± 0.59 and improved to 0.23 ± 0.22 at day 30 after the 
surgery. The intraocular pressure (IOP) remained stable and similar 
to the pre-operative measurements during the post-operative visits 
(p=0.004) (Figure 3). A mild inflammatory reaction (grade 0.5+ accor-
ding to SUN Working Group)(16) at the anterior chamber was observed 
within the first 7 days (Figure 4).
The pre-operative corneal pachymetry average was 538.8 ± 40.0 
and that on post-operative follow-up day 30 was 542.5 ± 39.8 (Figure 5). 
The preoperative endothelial cell count average was 2573.5 ± 235.9 and 
that on postoperative follow-up day 30 was 2311.36 ± 490.7 (Figure 6).
There were no significant differences between the results of pre- 
and post-operative fundus biomicroscopy.
QueStionnaireS
The questionnaires showed that surgeons considered Phacodyne™ 
to be efficient for staining the anterior capsule and that the staining 
facilitated the CCC procedure in all eyes (Table 1).
DISCUSSION
A previous study showed that a solution containing 1% soluble 
lutein-zeaxanthin and 0.04% Brilliant Blue G efficiently stained the 
anterior capsule and facilitated the CCC in cadaveric eyes(11). Additio-
nally, clinical, histological, and electroretinographic evaluations per-
formed after the intravitreal injection of the dye in rabbit eyes showed 
no signs of toxicity,(14) indicating the enhanced safety in case of 
accidental leak of the dye into the vitreous. Based on these reported 
we decided to evaluate the application of s the new dye for cataract 
surgery in humans.
Based on the nuclear cataract classification, LOCS III, the eyes 
enrolled in this study showed varying grades of cataract from 2 to 6, 
demonstrating that advanced cases of hypermature cataract were 
also present(6). The surgeons classified the visualization of the anterior 
capsule with the dye as “good” and considered it as a useful tool for 
cataract surgery (Table 1). The green colored dye (Figure 1) stained 
the anterior capsule of the lens, which facilitated the CCC procedure 
in all cases, including the hypermature cataracts.
The surgeons observed that in 4 eyes, the cornea, the incision, or 
iris were stained by the dye. Residual dye was found only in 2 eyes 
at the end of the surgical procedure (Table 1). The dye was not seen 
in any eye on the first postoperative day. A mild anterior chamber 
reaction of grade 0.5+ (according to SUN Working Group)(16) was 
observed during the first week after surgery (Figure 4). These results 
were similar to those of earlier clinical studies, where trypan blue 
was used during phacoemulsification to aid the CCC procedure or 
when a dye was not used.(3,4,17-19) In agreement with other reports, the 
IOP remained stable and similar to the pre-operative measurements 
during the post-operative period (Figure 3)(20).
The pre-operative BCVA (logMAR) was 0.89 ± 0.59 and improved 
to 0.23 ± 0.22 at day 30 after surgery, clearly showing that there was 
an improvement in BCVA from 20/160 to approximately 20/32 in 
Figure 3. Intraocular pressure (mmHg).
Figure 4. Post-operative anterior chamber reaction (+).
Figure 5. Corneal pachymetry (µm).
Figure 6. Endothelial cell count (/mm2).
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Table 1. Questionnaire returned by surgeons showing the effectiveness of the dye
Surgeons questionnaire response % p
How often do the surgeon use dyes in cataract surgery? Never 00 000%
Rarely 08 032%
Frequently 13 052%
Always 04 016%
Which dye does the surgeon use? Trypan blue 25 100%
Indocyanine green 00 000%
Others 00 000%
How was the visualization of the anterior capsule with Phacodyne? Good 25 100% p<0.001
Bad 00 000%
How was the degree of staining of the anterior lens capsule by the dye? Nothing 00 000% p<0.001
Adequate 20 080%
Intense 05 020%
Did it color any other ocular tissues? No 21 084% p<0.001
Yes 04 016%
Conjunctiva 00 000%
Iris 01 004%
Posterior capsule 00 000%
Incision 02 008%
Cornea 01 004%
What is the surgeon’s opinion about the usefulness of the dye? Good 25 100%
Bad 00 000%
Is the color of the dye suitable for dying the anterior lens capsule? Yes 25 100%
No 00 000%
Were there any signs of the dye at the end of the surgery? No 23 092% p<0.001
Yes 02 008%
Incision 02 008%
majority of the eyes. No signs of toxicity were observed during the 
30-day follow-up period(21).
Corneal pachymetric changes were observed soon after the sur-
gical procedure and peaked at one week during the follow-up. The 
values returned to the baseline levels on the 30th postoperative day. 
The pre-operative corneal pachymetry average was 538.8 ± 40.0 and 
the post-operative value was 542.5 ± 39.8 (Figure 5), demonstrating 
that anatomical changes of the cornea were temporary and reversi-
ble within the first 30 days after the surgery(21,22).
The baseline endothelial cell count average was 2573.5 ± 235.9 
and that post-operatively was 2311.36 ± 490.7 (Figure 6), showing 
an average decrease of 10.18% in the first month after the surgery. 
Similar endothelial cell loss during phacoemulsification procedures 
has been reported by others(21,22).
Pre-and post-operative fundus biomicroscopy evaluations showed 
no significant differences. Pre-and post-operative macular thickness 
measurements are needed to assess the effect on the retina.
To our knowledge, this is the first study that used a lutein-based 
dye (PhacodyneTM) for visualizing anterior capsulorhexis during ca-
taract surgery by phacoemulsification. However, our study had limi-
tations. This include, the small sample size, the absence of a control 
group, the large number of surgeons (that may affect the outcomes, 
although it is suitable for analyzing the efficacy), and the limited 
follow up period of 30 days. The goal of this study using lutein and 
zea xanthin combined with trypan blue was to evaluate the safety 
and efficacy of the dye for CCC. Further studies are warranted to eva-
luate the effectiveness of the new dye and its advantages over those 
that are currently being used. We hypothesize that use of lutein and 
zeaxanthin in combination with trypan blue may have two favorable 
effects: 1) The lower concentration of trypan blue (that can also be 
tested in more reduced concentrations in future studies(23)), and 2) 
the antioxidant effect of lutein and zeaxanthin molecules that may 
quench the singlet oxygen generated by the exposure of trypan blue 
to light. Additionally, since lutein is a natural product, the manufactu-
ring costs could be reduced. The use of lutein and zeaxanthin without 
trypan blue will be investigated in future studies.
CONCLUSION
The newly formulated lutein-based dye facilitated the CCC during 
phacoemulsification procedures and showed a good safety profile. 
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